Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/8491
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAcar, Göksemin-
dc.contributor.authorTanriöver, G.-
dc.contributor.authorDemir, R.-
dc.date.accessioned2019-08-16T12:41:14Z-
dc.date.available2019-08-16T12:41:14Z-
dc.date.issued2012-
dc.identifier.issn0161-6412-
dc.identifier.urihttps://hdl.handle.net/11499/8491-
dc.identifier.urihttps://doi.org/10.1179/1743132812Y.0000000068-
dc.description.abstractAngiogenesis, recruitment of new blood vessels, is an essential component of the metastatic pathway. These vessels provide the principal route by which tumor cells exit the primary tumor site and enter the circulation. For many tumors, the vascular density can provide a prognostic indicator of metastatic potential, with the highly vascular primary tumors having a higher incidence of metastasis than poorly vascular tumors. The discovery and characterization of tumor-derived angiogenesis modulators greatly contributed to our understanding of how tumors regulate angiogenesis. However, although angiogenesis appears to be a rate-limiting event in tumor growth and metastatic dissemination, a direct connection between the induction of angiogenesis and the progression to tumor malignancy is less well understood. In this review, we discuss the observations concerning the modulation of angiogenesis and their implications in various neurological disorders, as well as their potential impact on cancer therapy. © W. S. Maney & Son Ltd 2012.en_US
dc.language.isoenen_US
dc.relation.ispartofNeurological Researchen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAngiogenesisen_US
dc.subjectAnti-angiogenic therapiesen_US
dc.subjectNeurological disordersen_US
dc.subjectTumor metastasisen_US
dc.subjectangiogenesis inhibitoren_US
dc.subjectangiotensin IIen_US
dc.subjectbevacizumaben_US
dc.subjectcamptothecinen_US
dc.subjectcediraniben_US
dc.subjectcyclophosphamideen_US
dc.subjecterlotiniben_US
dc.subjectgefitiniben_US
dc.subjectgelatinase Aen_US
dc.subjectgelatinase Ben_US
dc.subjectimatiniben_US
dc.subjectlomustineen_US
dc.subjectnevaxaren_US
dc.subjectscatter factoren_US
dc.subjectsorafeniben_US
dc.subjectthrombospondin 1en_US
dc.subjectunclassified drugen_US
dc.subjectvasculotropinen_US
dc.subjectvatalaniben_US
dc.subjectangiogenesisen_US
dc.subjectantiangiogenic activityen_US
dc.subjectarteriovenous malformationen_US
dc.subjectblood brain barrieren_US
dc.subjectbrain blood vesselen_US
dc.subjectbrain diseaseen_US
dc.subjectbrain metastasisen_US
dc.subjectcancer chemotherapyen_US
dc.subjectcancer growthen_US
dc.subjectcancer prognosisen_US
dc.subjectcell proliferationen_US
dc.subjectcompetitive inhibitionen_US
dc.subjectdown regulationen_US
dc.subjectdrug efficacyen_US
dc.subjectglioblastomaen_US
dc.subjecthemangioblastomaen_US
dc.subjecthereditary hemorrhagic telengiectasiaen_US
dc.subjecthistopathologyen_US
dc.subjecthumanen_US
dc.subjecthypertensionen_US
dc.subjecthypoxemiaen_US
dc.subjectmacrophageen_US
dc.subjectmaximum tolerated doseen_US
dc.subjectmeningiomaen_US
dc.subjectneurologic diseaseen_US
dc.subjectoverall survivalen_US
dc.subjectprogression free survivalen_US
dc.subjectprotein expressionen_US
dc.subjectprotein secretionen_US
dc.subjectreviewen_US
dc.subjectsignal transductionen_US
dc.subjectthrombocytopeniaen_US
dc.subjecttumor cellen_US
dc.subjecttumor localizationen_US
dc.subjecttumor vascularizationen_US
dc.subjectupregulationen_US
dc.subjectvascular tumoren_US
dc.subjectAngiogenesis Inhibitorsen_US
dc.subjectAnimalsen_US
dc.subjectBrain Neoplasmsen_US
dc.subjectHumansen_US
dc.subjectNeovascularization, Pathologicen_US
dc.subjectNervous System Diseasesen_US
dc.titleAngiogenesis in neurological disorders: A reviewen_US
dc.typeReviewen_US
dc.identifier.volume34en_US
dc.identifier.issue7en_US
dc.identifier.startpage627-
dc.identifier.startpage627en_US
dc.identifier.endpage635en_US
dc.authorid0000-0001-8068-9060-
dc.identifier.doi10.1179/1743132812Y.0000000068-
dc.relation.publicationcategoryDiğeren_US
dc.identifier.pmid22889669en_US
dc.identifier.scopus2-s2.0-84865140991en_US
dc.identifier.wosWOS:000307532500001en_US
dc.identifier.scopusqualityQ2-
dc.ownerPamukkale University-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeReview-
item.grantfulltextnone-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

3
checked on Nov 16, 2024

WEB OF SCIENCETM
Citations

3
checked on Nov 21, 2024

Page view(s)

34
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.